RUM Group Inc. Class A Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? RUM Group Inc. Class A Common Stock trades at $6 (market cap $2.68B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: RUM Group Inc. Class A Common Stock is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, RUM Group Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold RUM Group Inc. Class A Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| RUM | VIR | |
|---|---|---|
Market Cap | $2.68B | $1.80B |
Volume | 3,201,203 | 1,782,836 |
Sector | Media | Health |
52-Week High | $10.23 | $11.78 |
52-Week Low | $4.67 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.98B | $1.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
RUM Group Inc., formerly Rumble Inc., is a holding company operating two business units: Rumble, an online video-sharing platform, and Quake AI, a cloud computing and artificial-intelligence infrastructure business.
Read more on RUM →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →